摘要
由于药品的复杂性,即使通过审批的药品,也会引起一些不良反应,包括肝毒性、肾毒性,甚至一些更严重的药品不良反应。我国实行严格的药品抽验制度,对于及时发现假药、劣质药具有重要意义,但一些不良反应的发生可能会给本身患病时用于诊治疾病的费用就不低的患者带去更大的经济负担。文章希望通过研究在不良反应补偿救助领域走在前列的一些国家的经验,结合我国目前现状,提出适合我国的药品不良反应补偿模式的构想。
Qualified drugs could also cause some kind of adverse reactions including hepatotoxicity, nephrotoxicity or other worse adverse reactions due to the complexity of drug. China have implemented strict policy of random testing on medicines, it’s important for timely detection on cunterfeit and substandard drugs. But we do not have regulations about compensating victims or specifying subjects of liability. That may give those patients unbearable burden and cause some bad influence for the whole society. Germany, Japan and United States have already had a perfect compensation mode because of the thalidomide crisis. We want to analysis compensation mode implemented by those countries in order to provide a vision of establishing ADR compensation mode which adapt to the situation of our country.
作者
李新
刘胤岐
臧恒昌
LI Xin;LIU Yinqi;ZANG Hengchang(School of Health Care Management,Shandong University,Ji’nan Shandong 250012,China;Key Laboratory of Health Comission for Economy and Policy Research,Ji’nan Shandong 250012,China)
出处
《中国继续医学教育》
2019年第34期88-91,共4页
China Continuing Medical Education
关键词
药品不良反应
损害
补偿
救济制度
构建
体系
药品安全
adverse drug reaction
damage
compensation
relief system
establishment
drug safety
